Biotech | February 21, 2022
Binnopharm acquires two anti-bacterial brands from Dr. Reddy’s
Dr. Reddy’s, will focus its resources and capabilities on its key therapy spaces of gastroenterology, pain management, cold and flu, allergy, oncology, neurology, paediatrics and women’s health as the Russia and CIS region continues to be a strong performer for the company
